Current & Future Treatments Possible by Banking
Bank today to ensure a safer tomorrow.
How are Stem Cells from Cord Blood & Tissue Used?
Your baby’s newborn stem cells in cord blood and mesenchymal stem cells in cord tissue have so much potential to save lives. Cord blood contains typical elements of blood such as red blood cells, white blood cells, platelets and plasma. Hematopoietic stem cells which are similar to those found in bone marrow can be used for transplantation as an alternative to bone marrow donated by an adult. Your baby’s umbilical cord contains tissue and blood that are rich sources of these powerful stem cells. Cord blood stem cells have already been used in more than 45,000 transplants worldwide (National Cord Blood Program). Beyond existing uses for cord blood stem cells, researchers are continuing to open new doors into the potential use of newborn stem cells in regenerative medicine for future treatments.
Current Treatments
Currently stem cells can treat over 80 different diseases including certain types of cancers, blood disorders, immune deficiencies, and metabolic diseases. More and more people are banking their children’s cord blood every year due to its amazing ability to treat a wide variety of diseases.
Future Treatments
Our focus is on your future. Clinical trials using cord blood and cord tissue stem cells are currently looking to reveal ways they may play a role in regenerative medicine. Researchers hope to find new approaches to healing the body using the cells’ natural abilities to help repair and regenerate.
Current Treatments
Malignancy
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Burkitt’s Lymphoma
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hodgkin’s Disease (Lymphoma)
- Juvenile Chronic Myelogenous Leukemia
- Juvenile Myelo-Monocytic Leukemia
- Lymphoma (type not specified)
- Multiple Myeloma
- Neuroblastoma
- Non-Hodgkin’s Lymphoma
Immune Deficiency/Disorder
- Adenosine Deaminase Deficiency
- Chronic Granulomatous Disease
- DiGeorge Syndrome
- Griscelli Syndrome
- Idiopathic Thrombocytopenic Purpura
- Immune Dysregulation
- Polyendocrinopathy
- Enteropathy
- X-linked (IPEX) Syndrome
- Omenn Syndrome
- Myelokathexis
- Reticular Dysgenesis
- Severe Combined Immune Deficiency (and related diseases)
- Systemic Lupus Erythematosus
- Thymic Dysplasia
- Wiskott-Aldrich Syndrome’
- X-Linked Agammaglobulinemia
- X-Linked Lymphoproliferative Disorder
Blood Cell Defect
- Chediak-Higashi Syndrome
- Chronic Granulomatous Disease
- Congenital Neutropenia
- Diamond-Blackfan Anemia
- Familial Erythrophagocytic Lymphohistiocytosis
- Fanconi Anemia
- Glanzmann Thrombasthenia
- Hemophagocytic Lymphohistiocytosis
- Histiocytoses
- Kostmann Syndrome
- Langerhans Cell Histiocytosis
- Lymphocyte Adhesion Disease
- Lymphoproliferative Syndrome
- Metachromatic Leukodystrophy
- Myelodysplastic syndrome
- Myelofibrosis
- Neutrophil Diseases
- Nezelof Syndrome
- Osteopetrosis
- Paroxysmal Nocturnal Hemoglobinuria
- Platelet Diseases
- Severe Aplastic Anemia
- Shwachman-Diamond Syndrome
- Sickle Cell Disease
- Sideroblastic Anemia
- Thalassemia (b Thalassemia)
- X-linked HyperIgM Syndrome
Metabolic Disease/Disorder
- Adrenoleukodystrophy
- Alpha-Mannosidosis(a-Mannosidosis)
- Amegakaryocytic Thrombocytopenia
- Aspartylglucosaminuria
- Congenital Erythropoietic Porphyria
- Dyskeratosis Congenita
- Fucosidosis
- Gangliosidosis
- Gaucher Disease
- Hurler Disease
- Hurler-Scheie Disease
- I-cell Disease
- Infantile Ceroid Lipofucoscinosis
- Krabbe Disease
- Lesch-Nyhan Syndrome
- Maroteaux-Lamy Syndrome
- Morquio Syndrome
- Sanfilippo Disease
- Sanhoff Diease
- Sialidosis
- TaySach Disease
- Wolman Disease
Future Treatments
Stem cells can help heal the body, accelerate recovery times, and provide countless therapeutic benefits. Doctors are continuing to research more ways to use cord blood and cord tissue stem cells to treat additional diseases. Cord blood and cord tissue are currently being used in different phases of clinical trials for several debilitating diseases. HealthBanks aims to grow availability of new clinical applications of newborn stem cells for families with conditions that currently have no cure through regenerative medicine.
Cord Blood Stem Cells
- Acquired hearing Loss
- Autism
- Cerebral Palsy
- Hypoplastic Left Heart Syndrome
- Neonatal Oxygen Deprivation
- Stroke
- Type 1 Diabetes
- Cartilage Repair
- Critical Limb Ischemia
- HIV
- Neurodegenerative Disorders
- Premature Lungs
- Traumatic Brain Injury
Cord Tissue Stem Cells
- Alzheimers Disease
- Aplasticanemis
- Cardiomyopathy
- Cartilage Repair
- Cerebral Palsy
- Connective Tissue Diseases
- Diabetes (type 2)
- Erectile Dysfunction
- Liver Failure
- Lung Injury
- Lupus
- Multiple Sclerosis
- Muscular Dystrophy
Cord Tissue Stem Cells Continued
- Myocardial Infrction
- Osteoarthritis
- Ovarian Failure
- Psoriasis
- Parkinsons Disease
- Retinitis Pigmentosa
- Rheumatoid Arthritis
- Sepsis
- Spinal Cord Injury
- Stroke
- Traumatic Optic Neuropathy
- Ulcerative Colitis
Subscribe to Our Newsletter & Special Promotions
Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.
HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.